174 related articles for article (PubMed ID: 30862875)
1. Deletion of tumour necrosis factor α receptor 1 elicits an increased TH17 immune response in the chronically inflamed liver.
Berkhout L; Barikbin R; Schiller B; Ravichandran G; Krech T; Neumann K; Sass G; Tiegs G
Sci Rep; 2019 Mar; 9(1):4232. PubMed ID: 30862875
[TBL] [Abstract][Full Text] [Related]
2. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
[TBL] [Abstract][Full Text] [Related]
3. Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis.
Ji T; Li G; Chen J; Zhao J; Li X; Lin H; Cai X; Cang Y
Oncotarget; 2016 Oct; 7(41):66635-66646. PubMed ID: 27556180
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.
Tedesco D; Thapa M; Chin CY; Ge Y; Gong M; Li J; Gumber S; Speck P; Elrod EJ; Burd EM; Kitchens WH; Magliocca JF; Adams AB; Weiss DS; Mohamadzadeh M; Grakoui A
Gastroenterology; 2018 Jun; 154(8):2178-2193. PubMed ID: 29454797
[TBL] [Abstract][Full Text] [Related]
5. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
[TBL] [Abstract][Full Text] [Related]
6. Early heme oxygenase 1 induction delays tumour initiation and enhances DNA damage repair in liver macrophages of Mdr2
Barikbin R; Berkhout L; Bolik J; Schmidt-Arras D; Ernst T; Ittrich H; Adam G; Parplys A; Casar C; Krech T; Karimi K; Sass G; Tiegs G
Sci Rep; 2018 Nov; 8(1):16238. PubMed ID: 30389969
[TBL] [Abstract][Full Text] [Related]
7. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
Potikha T; Stoyanov E; Pappo O; Frolov A; Mizrahi L; Olam D; Shnitzer-Perlman T; Weiss I; Barashi N; Peled A; Sass G; Tiegs G; Poirier F; Rabinovich GA; Galun E; Goldenberg D
Hepatology; 2013 Jul; 58(1):192-204. PubMed ID: 23423643
[TBL] [Abstract][Full Text] [Related]
8. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.
Stoyanov E; Ludwig G; Mizrahi L; Olam D; Schnitzer-Perlman T; Tasika E; Sass G; Tiegs G; Jiang Y; Nie T; Kohler J; Schinazi RF; Vertino PM; Cedar H; Galun E; Goldenberg D
Oncotarget; 2015 May; 6(13):11047-60. PubMed ID: 25918251
[TBL] [Abstract][Full Text] [Related]
9. Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis.
Affò S; Rodrigo-Torres D; Blaya D; Morales-Ibanez O; Coll M; Millán C; Altamirano J; Arroyo V; Caballería J; Bataller R; Ginès P; Sancho-Bru P
PLoS One; 2015; 10(12):e0145147. PubMed ID: 26691857
[TBL] [Abstract][Full Text] [Related]
10. A lymphotoxin-driven pathway to hepatocellular carcinoma.
Haybaeck J; Zeller N; Wolf MJ; Weber A; Wagner U; Kurrer MO; Bremer J; Iezzi G; Graf R; Clavien PA; Thimme R; Blum H; Nedospasov SA; Zatloukal K; Ramzan M; Ciesek S; Pietschmann T; Marche PN; Karin M; Kopf M; Browning JL; Aguzzi A; Heikenwalder M
Cancer Cell; 2009 Oct; 16(4):295-308. PubMed ID: 19800575
[TBL] [Abstract][Full Text] [Related]
11. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
[TBL] [Abstract][Full Text] [Related]
12. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation.
D'Mello C; Le T; Swain MG
J Neurosci; 2009 Feb; 29(7):2089-102. PubMed ID: 19228962
[TBL] [Abstract][Full Text] [Related]
13. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
[TBL] [Abstract][Full Text] [Related]
14. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
[TBL] [Abstract][Full Text] [Related]
16. Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
Mohs A; Kuttkat N; Reißing J; Zimmermann HW; Sonntag R; Proudfoot A; Youssef SA; de Bruin A; Cubero FJ; Trautwein C
J Hepatol; 2017 Apr; 66(4):743-753. PubMed ID: 28011329
[TBL] [Abstract][Full Text] [Related]
17. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
18. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
20. Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice.
Kong L; Zhou Y; Bu H; Lv T; Shi Y; Yang J
J Exp Clin Cancer Res; 2016 Sep; 35(1):131. PubMed ID: 27589954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
